Deutsche Bank Ag\ Alx Oncology Holdings Inc Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Deutsche Bank Ag\ holds 16,283 shares of ALXO stock, worth $29,146. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,283

Previous 10,434 56.06%

Holding current value

$29,146

Previous $62,000 53.23%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$1.81 - $8.13 $10,586 - $47,552	5,849 Added 56.06%	16,283 $29,000
Q2 2024 Aug 14, 2024	SELL	$5.84 - $17.56 $6,155 - $18,508	-1,054 Reduced 9.17%	10,434 $62,000
Q1 2024 May 15, 2024	BUY	$10.95 - $16.79 $4,007 - $6,145	366 Added 3.29%	11,488 $128,000
Q4 2023 Feb 14, 2024	BUY	$4.81 - $15.38 $1,601 - $5,121	333 Added 3.09%	11,122 $165,000
Q3 2023 Nov 09, 2023	SELL	$4.19 - $7.35 $765,454 - $1.34 Million	-182,686 Reduced 94.42%	10,789 $51,000
Q2 2023 Aug 14, 2023	SELL	$4.37 - $9.56 $669,982 - $1.47 Million	-153,314 Reduced 44.21%	193,475 $1.45 Million
Q1 2023 May 15, 2023	BUY	$4.52 - $11.71 $20,041 - $51,922	4,434 Added 1.3%	346,789 $1.57 Million
Q4 2022 Feb 13, 2023	BUY	$9.51 - $12.95 $1,350 - $1,838	142 Added 0.04%	342,355 $3.86 Million
Q3 2022 Nov 14, 2022	BUY	$8.23 - $15.14 $3,242 - $5,965	394 Added 0.12%	342,213 $3.28 Million
Q2 2022 Aug 11, 2022	SELL	$5.89 - $19.46 $10,861 - $35,884	-1,844 Reduced 0.54%	341,819 $2.77 Million
Q1 2022 May 13, 2022	BUY	$13.65 - $22.06 $4.54 Million - $7.33 Million	332,243 Added 2909.31%	343,663 $5.81 Million
Q4 2021 Feb 11, 2022	SELL	$21.49 - $74.4 $90,322 - $312,703	-4,203 Reduced 26.9%	11,420 $245,000
Q3 2021 Nov 04, 2021	BUY	$52.51 - $80.91 $228,943 - $352,767	4,360 Added 38.71%	15,623 $1.15 Million
Q2 2021 Aug 11, 2021	SELL	$52.2 - $75.23 $18,009 - $25,954	-345 Reduced 2.97%	11,263 $616,000
Q1 2021 May 13, 2021	BUY	$62.84 - $87.68 $281,271 - $392,455	4,476 Added 62.76%	11,608 $855,000
Q4 2020 Feb 16, 2021	BUY	$34.11 - $112.26 $69,038 - $227,214	2,024 Added 39.62%	7,132 $615,000
Q3 2020 Nov 12, 2020	BUY	$29.36 - $47.1 $149,970 - $240,586	5,108 New	5,108 $193,000

Others Institutions Holding ALXO

# of Institutions

101

Shares Held

39.7M

Call Options Held

134K

Put Options Held

17.4K

View Full List

About ALX ONCOLOGY HOLDINGS INC

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $72.9M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

More about ALXO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account